Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

0Q6H

Hofseth Biocare Asa (0Q6H)

Hofseth Biocare Asa
일자:
정렬 기준:
 검색 관련기사 보기:LSE:0Q6H
일자시간출처헤드라인심볼기업
2025/02/2116:30UK RegulatoryHofseth Biocare ASA: HBC ACCELERATES IN HUMAN HEALTH AND PET NUTRITION THROUGH A STRATEGIC PARTNERSHIP WITH SYMRISE TO BUILD OUT BERKÅK, TRIPLING THE MANUFACTURING CAPACITY OF THE GROUPLSE:0Q6HHofseth Biocare Asa
2025/02/2102:18UK RegulatoryHofseth Biocare ASA: PRIMARY INSIDER NOTIFICATIONLSE:0Q6HHofseth Biocare Asa
2025/02/1416:45UK RegulatoryHofseth Biocare ASA: FOURTH QUARTER & FULL YEAR 2024 FINANCIAL REPORTLSE:0Q6HHofseth Biocare Asa
2024/12/1223:07UK RegulatoryHofseth Biocare ASA: PRIMARY INSIDER NOTIFICATIONLSE:0Q6HHofseth Biocare Asa
2024/12/0517:00UK RegulatoryHofseth Biocare ASA: Commences the project for a second hydrolysis plant in Norway to triple capacityLSE:0Q6HHofseth Biocare Asa
2024/11/0816:15UK RegulatoryHofseth Biocare ASA: THIRD QUARTER 2024 FINANCIAL REPORTLSE:0Q6HHofseth Biocare Asa
2024/10/2217:55UK RegulatoryHofseth Biocare ASA: CFO RESIGNATIONLSE:0Q6HHofseth Biocare Asa
2024/10/0815:45UK RegulatoryHofseth Biocare ASA: HBC IMMUNOLOGY COMPLETES IN VIVO DRUG LEAD STUDIES FOR PROSTATE CANCER TREATMENTLSE:0Q6HHofseth Biocare Asa
2024/08/2315:00UK RegulatoryHofseth Biocare ASA: SECOND QUARTER AND HALF YEAR 2024 FINANCIAL REPORTLSE:0Q6HHofseth Biocare Asa
2024/08/1420:09UK RegulatoryHofseth Biocare ASA: GROUNDBREAKING STUDY REVEALS HOFSETH BIOCARE’S FULL SPECTRUM OMEGAS OMEGO SUPPORTS COVID-19 RECOVERYLSE:0Q6HHofseth Biocare Asa
2024/07/0216:00UK RegulatoryHofseth Biocare ASA: HBC discovers new drug candidate for asthma and transfers it to HBC Immunology Inc.LSE:0Q6HHofseth Biocare Asa
2024/06/1116:00UK RegulatoryHofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHYLSE:0Q6HHofseth Biocare Asa
2024/05/1615:00UK RegulatoryHofseth Biocare ASA: FIRST QUARTER 2024 FINANCIAL REPORTLSE:0Q6HHofseth Biocare Asa
2024/05/1021:30UK RegulatoryHofseth Biocare ASA: Annual General Meeting completedLSE:0Q6HHofseth Biocare Asa
2024/04/1920:00UK RegulatoryHofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2024LSE:0Q6HHofseth Biocare Asa
2024/04/1915:00UK RegulatoryHofseth Biocare ASA: HBC ANNUAL REPORT 2023LSE:0Q6HHofseth Biocare Asa
2024/04/0601:08UK RegulatoryHofseth Biocare ASA: DISCLOSURE OF LARGE SHAREHOLDINGLSE:0Q6HHofseth Biocare Asa
2024/03/2118:40UK RegulatoryHofseth Biocare ASA: UPDATED COMPANY PRESENTATIONLSE:0Q6HHofseth Biocare Asa
2024/03/1420:12UK RegulatoryHofseth Biocare ASA: CHAIR KRISTIN FJELLBY GRUNG STEPS DOWNLSE:0Q6HHofseth Biocare Asa
2024/02/0916:00UK RegulatoryHofseth Biocare ASA: FOURTH QUARTER 2023 AND FULL YEAR FINANCIAL REPORTLSE:0Q6HHofseth Biocare Asa
2024/02/0623:56UK RegulatoryHofseth Biocare ASA: HBC Immunology Inc successfully completes first animal model of prostate cancer with FT-005 in combination with hormonal (anti-androgen) therapy demonstrating significant anti-tumour activityLSE:0Q6HHofseth Biocare Asa
 검색 관련기사 보기:LSE:0Q6H